TP53 and neoplasm: SAPCS identified two African-specific mutational subtypes in PCa: one predominated by driver gene copy number (CN) gain and included enrichment for driver mutations in KMT2C, MTOR, and TP53 among inferred tumour subclones, while the second demonstrated a combination of CN gain and hemizygous loss in cancer drivers.